{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:02:32Z","timestamp":1765609352835},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11894-008-0005-z","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T14:03:36Z","timestamp":1201788216000},"page":"22-29","source":"Crossref","is-referenced-by-count":11,"title":["Hepatorenal syndrome: Current management"],"prefix":"10.1007","volume":"10","author":[{"given":"Florence","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,1]]},"reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"A. Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Escorsell A, Gin\u00e8s P, et al.: Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993, 105:229\u2013236.","journal-title":"Gastroenterology"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","volume":"41","author":"C. Alessandria","year":"2005","unstructured":"Alessandria C, Ozdogan O, Guevara M, et al.: MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005, 41:1282\u20131289.","journal-title":"Hepatology"},{"key":"5_CR3","first-page":"1310","volume":"56","author":"F. Salerno","year":"2007","unstructured":"Salerno F, Gerbes A, Gin\u00e8s P, et al.: Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007, 56:1310\u20131318.","journal-title":"Gut"},{"key":"5_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","volume":"45","author":"S. Fasolato","year":"2007","unstructured":"Fasolato S, Angeli P, Dallagnese L, et al.: Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007, 45:223\u2013229.","journal-title":"Hepatology"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","volume":"46","author":"V. Arroyo","year":"2007","unstructured":"Arroyo V, Terra C, Gin\u00e8s P: Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol 2007, 46:935\u2013946.","journal-title":"J Hepatol"},{"key":"5_CR6","volume-title":"Current Diagnosis and Treatment in Nephrology and Hypertension","author":"F. Wong","year":"2007","unstructured":"Wong F: Hepatorenal syndrome. In Current Diagnosis and Treatment in Nephrology and Hypertension. Edited by Lerma EV, Nissenson AR, Berns JS. New York: McGraw Hill Press; 2007, [In press]."},{"key":"5_CR7","doi-asserted-by":"crossref","unstructured":"Stadlbauer V, Wright GAK, Banaji M, et al.: Relationship between activation of the sympathetic nervous system and renal blood flow auto regulation in cirrhosis. Gastroenterology 2008, [In press].","DOI":"10.1053\/j.gastro.2007.10.055"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","volume":"40","author":"F. Wong","year":"2004","unstructured":"Wong F, Pantea L, Sniderman K: The use of midodrine, octreotide and transjugular intrahepatic portosystemic stent shunt in the treatment of cirrhotic patients with ascites and renal dysfunction including hepatorenal syndrome. Hepatology 2004, 40:55\u201364.","journal-title":"Hepatology"},{"key":"5_CR9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3748\/wjg.v12.i6.837","volume":"12","author":"H.Q. Liu","year":"2006","unstructured":"Liu HQ, Gaskari SA, Lee SS: Cardiac and vascular changes in cirrhosis: Pathogenic mechanisms. World J Gastroenterol 2006, 12:837\u2013842.","journal-title":"World J Gastroenterol"},{"key":"5_CR10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"L. Ruiz del Arbol","year":"2003","unstructured":"Ruiz del Arbol L, Urman J, Fernandez J, et al.: Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003, 38:1210\u20131218.","journal-title":"Hepatology"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L. Ruiz del Arbol","year":"2005","unstructured":"Ruiz del Arbol L, Monescillo A, Arocena C, et al.: Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005, 42:439\u2013447.","journal-title":"Hepatology"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncpgasthep0680","volume":"4","author":"F. Wong","year":"2007","unstructured":"Wong F: The role of albumin in the management of chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2007, 4:43\u201351.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0168-8278(07)61680-8","volume":"46","author":"M. Martin-Llahi","year":"2007","unstructured":"Martin-Llahi M, Pepin MN, Guevara M, et al.: Randomized comparative study of terlipressin and albumin vs albumin alone in patients with cirrhosis and hepatorenal syndrome [abstract]. J Hepatol 2007, 46:S36.","journal-title":"J Hepatol"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"R. Moreau","year":"2002","unstructured":"Moreau R, Durand F, Poynard T, et al.: Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002, 122:923\u2013930.","journal-title":"Gastroenterology"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1742-1241.1998.tb08933.x","volume":"52","author":"S.M. Lin","year":"1998","unstructured":"Lin SM, Lee CS, Kao PF: Low-dose dopamine infusion in cirrhosis with refractory ascites. Int J Clin Pract 1998, 52:533\u2013536.","journal-title":"Int J Clin Pract"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","volume":"29","author":"P. Angeli","year":"1999","unstructured":"Angeli P, Volpin R, Gerunda G, et al.: Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999, 29:1690\u20131697.","journal-title":"Hepatology"},{"key":"5_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0168-8278(05)80042-X","volume":"17","author":"A. Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s A, Salmer\u00f3n JM, Gin\u00e8s P, et al.: Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. J Hepatol 1993, 17:220\u2013226.","journal-title":"J Hepatol"},{"key":"5_CR18","doi-asserted-by":"crossref","unstructured":"Wong F, Moore K, Dingemanse J, Jalan R: Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome. Hepatology 2007, [ePub ahead of print].","DOI":"10.1002\/hep.21940"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","volume":"28","author":"P. Angeli","year":"1998","unstructured":"Angeli P, Volpin R, Piovan D, et al.: Acute effects of the oral administration of midodrine, an \u03b1-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology 1998, 28:937\u2013943.","journal-title":"Hepatology"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","volume":"38","author":"G. Pomier-Layrargues","year":"2003","unstructured":"Pomier-Layrargues G, Paquin SC, Hassoun Z, et al.: Octreotide in hepatorenal syndrome: a randomized, double blind, placebo-controlled, crossover study. Hepatology 2003, 38:238\u2013243.","journal-title":"Hepatology"},{"key":"5_CR21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","volume":"20","author":"T.H. Kiser","year":"2005","unstructured":"Kiser TH, Fish DN, Obritsch MD, et al.: Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study. Nephrol Dial Transplant 2005, 20:1813\u20131820.","journal-title":"Nephrol Dial Transplant"},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","volume":"24","author":"F. Fabrizi","year":"2006","unstructured":"Fabrizi F, Dixit V, Martin P: Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther 2006, 24:935\u2013944.","journal-title":"Aliment Pharmacol Ther"},{"key":"5_CR23","first-page":"694A","volume":"44","author":"A. Sanyal","year":"2006","unstructured":"Sanyal A, Boyer T, Garcia-Tsao G, et al.: A prospective randomized double blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS) [abstract]. Hepatology 2006, 44:694A.","journal-title":"Hepatology"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","volume":"1","author":"H.M. Wadei","year":"2006","unstructured":"Wadei HM, Mai ML, Ahsan N, et al.: Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol 2006, 1:1066\u20131079.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5_CR25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R. Ortega","year":"2002","unstructured":"Ortega R, Gin\u00e8s P, Uriz J, et al.: Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 2002, 36:941\u2013948.","journal-title":"Hepatology"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","volume":"14","author":"C. Alessandria","year":"2002","unstructured":"Alessandria C, Venon WD, Marzano A, et al.: Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2. Eur J Gastroenterol Hepatol 2002, 14:1363\u20131368.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jhep.2007.04.010","volume":"47","author":"C. Alessandria","year":"2007","unstructured":"Alessandria C, Ottobrelli A, Debernardi-Venon W, et al.: Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol 2007, 47:495\u2013505.","journal-title":"J Hepatol"},{"key":"5_CR28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","volume":"36","author":"C. Duvoux","year":"2002","unstructured":"Duvoux C, Zanditenas D, Hezode C, et al.: Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 2002, 36:374\u2013380.","journal-title":"Hepatology"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","volume":"349","author":"K.A. Brensing","year":"1997","unstructured":"Brensing KA, Textor J, Strunk H, et al.: Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 1997, 349:697\u2013698.","journal-title":"Lancet"},{"key":"5_CR30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","volume":"47","author":"K.A. Brensing","year":"2000","unstructured":"Brensing KA, Textor J, Perz J, et al.: Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000, 47:288\u2013295.","journal-title":"Gut"},{"key":"5_CR31","first-page":"1753","volume":"50","author":"G. Testino","year":"2003","unstructured":"Testino G, Ferro C, Sumberaz A, et al.: Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 2003, 50:1753\u20131755.","journal-title":"Hepatogastroenterology"},{"key":"5_CR32","first-page":"1169","volume":"90","author":"L. Spahr","year":"1995","unstructured":"Spahr L, Fenyves D, Nguyen VV, et al.: Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 1995, 90:1169\u20131171.","journal-title":"Am J Gastroenterol"},{"key":"5_CR33","first-page":"1766","volume":"25","author":"J.R. Lake","year":"1993","unstructured":"Lake JR, Ring E, LaBerge J, et al.: Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc 1993, 25:1766\u20131767.","journal-title":"Transplant Proc"},{"key":"5_CR34","first-page":"985","volume":"42","author":"J. Lerut","year":"1995","unstructured":"Lerut J, Goffette P, Laterre PF, et al.: Sequential treatment of hepatorenal syndrome and post hepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation. Hepatogastroenterology 1995, 42:985\u2013987.","journal-title":"Hepatogastroenterology"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","volume":"28","author":"M. Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Bandi JC, et al.: Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998, 28:416\u2013422.","journal-title":"Hepatology"},{"key":"5_CR36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1525-1594.1993.tb00635.x","volume":"17","author":"J. Stange","year":"1993","unstructured":"Stange J, Ramlow W, Mitzner S, et al.: Dialysis against a recycled albumin solution enables the removal of albuminbound toxins. Artif Organs 1993, 17:809\u2013813.","journal-title":"Artif Organs"},{"key":"5_CR37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","volume":"6","author":"S.R. Mitzner","year":"2000","unstructured":"Mitzner SR, Stange J, Klammt S, et al.: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000, 6:277\u2013286.","journal-title":"Liver Transpl"},{"key":"5_CR38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.20236","volume":"10","author":"S. Sen","year":"2004","unstructured":"Sen S, Davies NA, Mookerjee RP, et al.: Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004, 10:1109\u20131119.","journal-title":"Liver Transpl"},{"key":"5_CR39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1021763221337","volume":"48","author":"C. Cassinello","year":"2003","unstructured":"Cassinello C, Moreno E, Gozalo A, et al.: Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci 2003, 48:179\u2013186.","journal-title":"Dig Dis Sci"},{"key":"5_CR40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","volume":"21","author":"P.E. Marik","year":"2006","unstructured":"Marik PE, Wood K, Starzl TE: The course of type 1 hepatorenal syndrome post liver transplantation. Nephrol Dial Transplant 2006, 21:478\u2013482.","journal-title":"Nephrol Dial Transplant"},{"key":"5_CR41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hep.1840170202","volume":"17","author":"A. Hadengue","year":"1993","unstructured":"Hadengue A, Lebrec D, Moreau R, et al.: Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 1993, 17:175\u2013178.","journal-title":"Hepatology"},{"key":"5_CR42","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","volume":"35","author":"S. Nair","year":"2002","unstructured":"Nair S, Verma S, Thuluvath PJ: Pre-transplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002, 35:1179\u20131185.","journal-title":"Hepatology"},{"key":"5_CR43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","volume":"59","author":"T.A. Gonwa","year":"1995","unstructured":"Gonwa TA, Klintmalm GB, Levy M, et al.: Impact of pre-transplant renal function on survival after liver transplantation. Transplantation 1995, 59:361\u2013365.","journal-title":"Transplantation"},{"key":"5_CR44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","volume":"40","author":"T. Restuccia","year":"2004","unstructured":"Restuccia T, Ortega R, Guevara M, et al.: Effects of treatment of hepatorenal syndrome before transplantation on post-transplantation outcome. A case-control study. J Hepatol 2004, 40:140\u2013146.","journal-title":"J Hepatol"},{"key":"5_CR45","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","volume":"7","author":"C.L. Davis","year":"2007","unstructured":"Davis CL, Feng S, Sung R, et al.: Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 2007, 7:1702\u20131709.","journal-title":"Am J Transplant"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-008-0005-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0005-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T21:07:18Z","timestamp":1708549638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-008-0005-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s11894-008-0005-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}